We are live on ! Find out more
TD Asset Management

TD Asset Management Portfolio holdings

AUM $123B
1-Year Est. Return 34.51%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$81B
AUM Growth
+$1.17B
Cap. Flow
-$2.37B
Cap. Flow %
-2.92%
Top 10 Hldgs %
26.64%
Holding
1,562
New
88
Increased
546
Reduced
606
Closed
117

Sector Composition

Rank Sector Weight
1 Financials 20.44%
2 Technology 17.09%
3 Healthcare 11.75%
4 Industrials 8.45%
5 Energy 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNF icon
1201
Fidelity National Financial
FNF
$13.9B
$732K ﹤0.01%
19,446
-1,506
-7% -$56.5K
FR icon
1202
First Industrial Realty Trust
FR
$8.68B
$730K ﹤0.01%
15,136
-18,000
-54% -$859K
AZTA icon
1203
Azenta
AZTA
$1.36B
$722K ﹤0.01%
+12,400
New +$634K
PTCT icon
1204
PTC Therapeutics
PTCT
$5.72B
$721K ﹤0.01%
18,897
-13,316
-41% -$554K
ARMK icon
1205
Aramark
ARMK
$15B
$719K ﹤0.01%
24,103
-416
-2% -$11.5K
FATE icon
1206
Fate Therapeutics
FATE
$295M
$715K ﹤0.01%
70,826
-18,700
-21% -$351K
IMRX icon
1207
Immuneering
IMRX
$270M
$712K ﹤0.01%
146,714
-947
-0.6% -$8.39K
DCPH
1208
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$711K ﹤0.01%
43,400
-5,300
-11% -$86.2K
TWST icon
1209
Twist Bioscience
TWST
$6.13B
$711K ﹤0.01%
29,874
-6,100
-17% -$177K
CNR
1210
Core Natural Resources Inc
CNR
$4.05B
$709K ﹤0.01%
10,900
+3,900
+56% +$263K
MLTX icon
1211
MoonLake Immunotherapeutics
MLTX
$1.51B
$707K ﹤0.01%
67,312
YELP icon
1212
Yelp
YELP
$1.47B
$703K ﹤0.01%
25,700
+17,300
+206% +$549K
BCYC
1213
Bicycle Therapeutics
BCYC
$270M
$698K ﹤0.01%
23,586
+8,000
+51% +$215K
CASH icon
1214
Pathward Financial
CASH
$1.9B
$697K ﹤0.01%
+16,200
New +$665K
ADPT icon
1215
Adaptive Biotechnologies
ADPT
$3.72B
$696K ﹤0.01%
91,119
DBX icon
1216
Dropbox
DBX
$7.74B
$694K ﹤0.01%
31,021
+12,613
+69% +$277K
MSA icon
1217
Mine Safety
MSA
$7.42B
$694K ﹤0.01%
4,810
-7,000
-59% -$917K
UUP icon
1218
Invesco DB US Dollar Index Bullish Fund
UUP
$424M
$692K ﹤0.01%
24,876
+6,781
+37% +$198K
SXC icon
1219
SunCoke Energy
SXC
$704M
$682K ﹤0.01%
79,000
+49,100
+164% +$379K
WAFD icon
1220
WaFd
WAFD
$2.75B
$674K ﹤0.01%
20,100
-12,900
-39% -$451K
FCNCA icon
1221
First Citizens BancShares
FCNCA
$25B
$670K ﹤0.01%
883
-31
-3% -$25K
ROKU icon
1222
Roku
ROKU
$21.7B
$666K ﹤0.01%
16,370
-8,918
-35% -$466K
CDRE icon
1223
Cadre Holdings
CDRE
$1.32B
$663K ﹤0.01%
32,902
ARES icon
1224
Ares Management
ARES
$30.6B
$660K ﹤0.01%
+9,639
New +$695K
SEER icon
1225
Seer Inc
SEER
$123M
$652K ﹤0.01%
112,332
-14,600
-12% -$98.5K

Similar funds

TD Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, TD Asset Management held 1,562 positions worth $81B, up 1.5% from $79.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TD Asset Management's Q4 2022 filing shows 88 new, 546 increased, 606 reduced and 117 closed positions. Its largest new stake was Brookfield Asset Management: 7,008,054 shares worth $201M. The largest sale was Alphabet (Google) Class C, an estimated $396M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

  • TD Asset Management's largest Q4 2022 buy was Brookfield Asset Management: 7,008,054 shares worth $201M.
  • TD Asset Management added most to iShares MSCI Japan ETF in Q4 2022, an estimated $258M increase.
  • TD Asset Management's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $396M.
  • TD Asset Management fully exited Corcept Therapeutics in Q4 2022, selling an estimated $25.4M.
  • TD Asset Management's ten largest holdings make up 27% of its $81B portfolio in Q4 2022.
  • TD Asset Management opened 88 new positions and closed 117 in Q4 2022.
  • TD Asset Management's portfolio value rose 1.5% quarter-over-quarter to $81B.

Based on TD Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.